Abstract
The letter by Kamar et al., advancements in our understanding of chronic hepatitis E infection in solid organ transplant patients over time are highlighted. They cite the 2019 publication on the importance of fecal hepatitis E PCR in determining clearance of chronic infection. However, our patient initially received ribavirin in 2013, with his second course in 2015, and his final treatment with ribavirin and sofosbuvir occurring in 2017.
This article is protected by copyright. All rights reserved.
http://bit.ly/2MVLB62
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.